+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bird Flu Treatment Market - Global Forecast 2026-2032- Product Image
Bird Flu Treatment Market - Global Forecast 2026-2032- Product Image
New

Bird Flu Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010916
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The avian influenza treatment market is undergoing significant transformation, driven by rapid advances in antiviral therapies, diagnostics, and supply chain management. As health and veterinary systems confront evolving outbreak threats, senior decision-makers must align clinical innovation, diagnostics readiness, and operational agility to maintain resilience across all segments of care.

Market Snapshot: Bird Flu Treatment Market Size and Growth

The Bird Flu Treatment Market grew from USD 25.86 billion in 2025 to USD 28.05 billion in 2026. It is expected to continue growing at a CAGR of 8.42%, reaching USD 45.55 billion by 2032. Rising zoonotic spillovers and advancing viral genetics have intensified demand for innovative antivirals, vaccines, and diagnostic solutions. Market drivers include integrated response requirements, new therapeutic modalities, and renewed focus on supply chain resilience.

Scope & Segmentation: Comprehensive Market Coverage

This report provides structured coverage of the global avian influenza treatment landscape, with detailed segmentation by product type, administration route, end user, application domain, region, and technology platform:

  • Product Types: Antiviral drugs (adamantanes, neuraminidase inhibitors, polymerase inhibitors, combination therapies); vaccines (inactivated, live attenuated, mRNA, recombinant); diagnostics (molecular diagnostics, point-of-care molecular systems, rapid test kits, serological tools); and supportive care solutions (oxygen therapy, rehydration, telehealth monitoring).
  • Administration Routes: Oral regimens (capsules, suspensions, tablets); inhaled therapies (dry powder, metered-dose inhalers, nebulizers); injectable options (intramuscular, subcutaneous, nanoparticle-based formats); intravenous infusions (central, peripheral, smart pump-enabled).
  • End Users: Clinics (community, outpatient, specialty); hospitals (public, private, specialized centers); laboratories (hospital-based, independent, point-of-care); pharmacies (mail order, online, retail).
  • Application Domains: Human health (adult, pediatric, geriatric populations); animal health (livestock, poultry, wild birds).
  • Regional Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific—each with unique regulatory frameworks, manufacturing capacity, and distribution realities.
  • Technology Platforms: Next-generation antivirals, mRNA and recombinant vaccines, high-sensitivity molecular diagnostics, digital health, telemonitoring, modular manufacturing.

Key Takeaways: Strategic Insights for Decision-Makers

  • Integrated clinical protocols are vital, with the success of treatment strategies depending on alignment between diagnostics capability and therapeutic administration across diverse care settings.
  • Therapeutic advancement now includes next-generation antivirals and vaccines, mRNA platforms, and adaptive manufacturing methods that speed up development and facilitate rapid deployment.
  • Diversification in delivery modalities is expanding targeted options, from grounded pulmonary therapies to remote-friendly oral and telehealth-enabled pathways.
  • Animal health is increasingly monitored using intensified surveillance and targeted vaccination, emphasizing the importance of cross-sector strategies for both veterinary and human populations.
  • Regional differences in logistics, regulatory approval timelines, and domestic production shape the location and resilience of manufacturing and diagnostics deployment.
  • Collaboration, transparency, and capability mapping are essential criteria for partner selection, ensuring that organizations can rapidly scale solutions in response to variable outbreak intensities.

Impact of Tariff Policy and Trade Dynamics

Cumulative tariff shifts and trade policy changes are reshaping global supply chains for avian influenza preparedness. These changes heighten procurement costs, extend lead times, and require manufacturers to seek alternative sourcing, invest in domestic capacity, and reconfigure logistics. Streamlined customs and public-private partnerships can mitigate disruptions, underscoring the importance of diversified supply chains and adaptive procurement models.

Methodology & Data Sources: Transparent, Multi-Faceted Approach

The findings synthesize peer-reviewed literature, regulatory guidance, and surveillance data, complemented by interviews with clinicians, laboratory leaders, manufacturers, and veterinary experts. Comparative technology evaluations, scenario analysis, and field validations were conducted to assess real-world constraints. The evidence base highlights both established modalities and emerging best practices while clearly noting the limitations of currently disclosed data.

Why This Report Matters: Actionable Insights for Leaders

  • Enables informed planning for therapeutic, diagnostic, and supply chain strategies by highlighting where product, technology, and operational needs intersect.
  • Supports risk mitigation and resilience planning by clarifying the impact of regulatory changes, regional disparities, and shifting supplier landscapes.
  • Facilitates strategic partner selection through transparent evaluation of innovation readiness, platform flexibility, and collaborative capability across the value chain.

Conclusion

Integrated innovation, supply chain agility, and cross-sector collaboration are critical in strengthening avian influenza preparedness. Aligning strategy with cutting-edge technology, robust diagnostics, and regional realities enables health systems to meet current and emerging challenges in both human and animal health domains.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bird Flu Treatment Market, by Product Type
8.1. Antiviral Drug
8.1.1. Adamantanes
8.1.2. Combination Therapy
8.1.3. Neuraminidase Inhibitors
8.1.4. Polymerase Inhibitors
8.2. Diagnostic Kit
8.2.1. Molecular Diagnostics
8.2.2. Point Of Care Molecular
8.2.3. Rapid Test Kits
8.2.4. Serological Diagnostics
8.3. Supportive Care
8.3.1. Oxygen Therapy
8.3.2. Rehydration Therapy
8.3.3. Symptom Management
8.3.4. Telehealth Monitoring
8.4. Vaccine
8.4.1. Inactivated Vaccine
8.4.2. Live Attenuated Vaccine
8.4.3. Mrna Vaccine
8.4.4. Recombinant Vaccine
9. Bird Flu Treatment Market, by Administration Route
9.1. Inhalation
9.1.1. Dry Powder Inhaler
9.1.2. Metered Dose Inhaler
9.1.3. Nebulizer
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Nanoparticle Delivery
9.2.3. Subcutaneous
9.3. Intravenous
9.3.1. Central Line
9.3.2. Peripheral Line
9.3.3. Smart Infusion Pumps
9.4. Oral
9.4.1. Capsule
9.4.2. Sublingual
9.4.3. Suspension
9.4.4. Tablet
10. Bird Flu Treatment Market, by End User
10.1. Clinics
10.1.1. Community Health Centers
10.1.2. Outpatient Clinics
10.1.3. Specialty Clinics
10.2. Hospitals
10.2.1. Private Hospitals
10.2.2. Public Hospitals
10.2.3. Specialized Care Centers
10.3. Laboratories
10.3.1. Hospital Labs
10.3.2. Independent Labs
10.3.3. Point Of Care Testing
10.4. Pharmacies
10.4.1. Mail Order Pharmacies
10.4.2. Online Pharmacies
10.4.3. Retail Pharmacies
11. Bird Flu Treatment Market, by Application
11.1. Animal Health
11.1.1. Livestock
11.1.2. Poultry
11.1.3. Wild Birds
11.2. Human Health
11.2.1. Adult Patients
11.2.2. Geriatric Patients
11.2.3. Pediatric Patients
12. Bird Flu Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Bird Flu Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bird Flu Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Bird Flu Treatment Market
16. China Bird Flu Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Alltech, Inc.
17.6. BioCryst Pharmaceuticals, Inc.
17.7. Boehringer Ingelheim International GmbH
17.8. Ceva Santé Animale
17.9. Cipla Limited
17.10. CSL Limited
17.11. F. Hoffmann-La Roche Ltd.
17.12. FATRO S.p.A.
17.13. Gilead Sciences, Inc.
17.14. GlaxoSmithKline PLC
17.15. Hester Biosciences Limited
17.16. Johnson & Johnson Services, Inc.
17.17. Macleods Pharmaceuticals Ltd
17.18. Merck KGaA
17.19. Moderna, Inc.
17.20. Novartis AG
17.21. PetSmart LLC
17.22. Pfizer Inc.
17.23. Sanofi S.A.
17.24. Serum Institute of India Pvt. Ltd.
17.25. Sinovac Biotech Ltd.
17.26. Takeda Pharmaceutical Company Limited
17.27. Tianjin Ringpu Biotechnology Co. Ltd.
17.28. Yebio Bioengineering Co. Ltd.
17.29. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADAMANTANES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADAMANTANES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADAMANTANES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POLYMERASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POLYMERASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RAPID TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RAPID TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SEROLOGICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SEROLOGICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SEROLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REHYDRATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REHYDRATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REHYDRATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SYMPTOM MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SYMPTOM MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SYMPTOM MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TELEHEALTH MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TELEHEALTH MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TELEHEALTH MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INACTIVATED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MRNA VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MRNA VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MRNA VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NANOPARTICLE DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NANOPARTICLE DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CENTRAL LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CENTRAL LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERIPHERAL LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERIPHERAL LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERIPHERAL LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SMART INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SMART INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SMART INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBLINGUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUBLINGUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALIZED CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALIZED CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SPECIALIZED CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MAIL ORDER PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MAIL ORDER PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MAIL ORDER PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY WILD BIRDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY WILD BIRDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY WILD BIRDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADULT PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADULT PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GERIATRIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GERIATRIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PEDIATRIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PEDIATRIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 222. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 280. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 281. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 282. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 283. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 284. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 285. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 286. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 287. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 288. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 289. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 290. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 291. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 293. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 294. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 295. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 296. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 297. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 298. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 299. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 301. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 302. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 303. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 304. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 305. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 306. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 307. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 308. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 309. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 310. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 311. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 312. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 313. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 314. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 315. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 316. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 317. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 318. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 319. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 320. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 321. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY DIAGNOSTIC KIT, 2018-2032 (USD MILLION)
TABLE 322. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 323. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 324. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 325. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 326. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018

Companies Mentioned

The key companies profiled in this Bird Flu Treatment market report include:
  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Cipla Limited
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • FATRO S.p.A.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hester Biosciences Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Ltd
  • Merck KGaA
  • Moderna, Inc.
  • Novartis AG
  • PetSmart LLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Tianjin Ringpu Biotechnology Co. Ltd.
  • Yebio Bioengineering Co. Ltd.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 28.05 Billion
Forecasted Market Value ( USD ) by 2032 $ 45.55 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Bird Flu Treatment Market - Global Strategic Business Report - Product Image

Bird Flu Treatment Market - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
H3N2 Infection - Pipeline Insight, 2025 - Product Image

H3N2 Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Influenza Medication Market - Global Forecast 2026-2032 - Product Image

Influenza Medication Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Influenza A Virus H5N1 Subtype - Pipeline Insight, 2025 - Product Image

Influenza A Virus H5N1 Subtype - Pipeline Insight, 2025

  • Drug Pipelines
  • 40 Pages
  • Global
From
Antivirals Market Report 2025 - Product Image

Antivirals Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Avian Influenza Drug Market

The Avian Influenza Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat avian influenza, a type of influenza virus that primarily affects birds, but can also infect humans. These drugs are used to reduce the severity of symptoms and prevent further spread of the virus. They are typically administered in the form of antiviral medications, such as oseltamivir and zanamivir. Vaccines are also available to help protect against avian influenza. The Avian Influenza Drug market is highly competitive, with many companies offering products to treat the virus. Some of the major players in the market include GlaxoSmithKline, Sanofi, Novartis, Merck, and Pfizer. Other companies, such as Cipla, Mylan, and Sun Pharmaceuticals, also offer products for the treatment of avian influenza. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.